(Q45734126)

15 December 2017

title

Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67. (English)

1 reference

15 December 2017

Dawei Li

1

1 reference

15 December 2017

Zhen Han

2

1 reference

15 December 2017

Jikai Liu

3

1 reference

15 December 2017

Xiang Zhang

4

1 reference

15 December 2017

Juchao Ren

5

1 reference

15 December 2017

Lei Yan

6

1 reference

15 December 2017

Hainan Liu

7

1 reference

15 December 2017

Zhonghua Xu

8

1 reference

15 December 2017

publication date

3 September 2013

1 reference

15 December 2017

1 reference

15 December 2017

volume

30

1 reference

15 December 2017

issue

4

1 reference

15 December 2017

page(s)

702

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-013-0702-9

15 December 2017

exact match

0 references

cites work

Falling incidence of penis cancer in an uncircumcised population (Denmark 1943-90)

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Penile cancer: epidemiology, pathogenesis and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

MYC copy number gains are associated with poor outcome in penile squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

The impact of cyclooxygenase-2 and vascular endothelial growth factor C immunoexpression on the prognosis of penile carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Partial purification and characterization of human hepatoma-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Hepatoma derived growth factor is a nuclear targeted mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

The expression and prognostic significance of hepatoma-derived growth factor in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Expression of hepatoma‐derived growth factor in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Biotin-free systems provide stronger immunohistochemical signal in oestrogen receptor evaluation of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

The prognostic value of Ki-67 expression in penile squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Mapping of the gene encoding the human hepatoma-derived growth factor (HDGF) with homology to the high-mobility group (HMG)-1 protein to Xq25

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Hepatoma-derived growth factor binds DNA through the N-terminal PWWP domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Hepatoma-derived growth factor stimulates podosome rosettes formation in NIH/3T3 cells through the activation of phosphatidylinositol 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

p16(INK4a) is a marker of good prognosis for primary invasive penile squamous cell carcinoma: a multi-institutional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Anatomical mapping of lymphatic drainage in penile carcinoma with SPECT-CT: implications for the extent of inguinal lymph node dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Accuracy of sentinel lymph node biopsy for inguinal lymph node staging of penile squamous cell carcinoma: systematic review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Population-based survival of penile cancer patients in Europe and the United States of America: No improvement since 1990

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0702-9

Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the penis

21 January 2018

1 reference

12 December 2020

p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy

1 reference

12 December 2020

mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior.

1 reference

12 December 2020

Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma

1 reference

12 December 2020

Can regional lymph node involvement be predicted in patients with carcinoma of the penis?

1 reference

12 December 2020

Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor. Its homology with high mobility group-1 protein

1 reference

12 December 2020

Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas

1 reference

12 December 2020

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

12 December 2020

Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer

1 reference

12 December 2020

Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer

1 reference

12 December 2020

Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma

1 reference

12 December 2020

Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells

1 reference

12 December 2020

SQUAMOUS-CELL EPITHELIOMA OF THE SKIN: A STUDY OF 256 CASES

1 reference

12 December 2020

Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival

1 reference

12 December 2020

Downregulation of hepatoma-derived growth factor suppresses the malignant phenotype of U87 human glioma cells

1 reference

12 December 2020

10.1007/S12032-013-0702-9

Identifiers

DOI

1 reference

Dimensions Publication ID

15 December 2017

1051207931

0 references

1 reference